BTS
CLB icon

BB&T Securities’s Core Laboratories CLB Stock Holding History

BB&T Securities’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$707K Buy
15,214
+1,836
+14% +$85.4K 0.01% 954
2019
Q2 		$699K Sell
13,378
-6,176
-32% -$362K 0.01% 958
2019
Q1 		$1.35M Buy
19,554
+7,913
+68% +$530K 0.01% 709
2018
Q4 		$694K Sell
11,641
-14,396
-55% -$1.24M 0.01% 866
2018
Q3 		$3.02M Buy
26,037
+3,841
+17% +$433K 0.03% 499
2018
Q2 		$2.8M Buy
22,196
+692
+3% +$84.2K 0.03% 516
2018
Q1 		$2.33M Buy
21,504
+3,810
+22% +$422K 0.03% 542
2017
Q4 		$1.94M Buy
17,694
+5,641
+47% +$563K 0.03% 544
2017
Q3 		$1.19M Sell
12,053
-6,514
-35% -$631K 0.02% 687
2017
Q2 		$1.88M Buy
18,567
+5,146
+38% +$555K 0.03% 533
2017
Q1 		$1.55M Sell
13,421
-977
-7% -$114K 0.02% 532
2016
Q4 		$1.62M Hold
14,398
– – 0.02% 493
2016
Q3 		$1.62M Buy
14,398
+3,151
+28% +$363K 0.02% 488
2016
Q2 		$1.39M Sell
11,247
-1,112
-9% -$134K 0.02% 507
2016
Q1 		$1.39M Buy
12,359
+647
+6% +$67.2K 0.02% 492
2015
Q4 		$1.27M Buy
11,712
+3,705
+46% +$424K 0.03% 458
2015
Q3 		$799K Buy
8,007
+373
+5% +$40.6K 0.02% 569
2015
Q2 		$870K Buy
7,634
+1,134
+17% +$138K 0.02% 570
2015
Q1 		$679K Sell
6,500
-3,737
-37% -$398K 0.01% 629
2014
Q4 		$1.23M Buy
10,237
+617
+6% +$81K 0.03% 453
2014
Q3 		$1.41M Sell
9,620
-224
-2% -$34.6K 0.03% 378
2014
Q2 		$1.64M Buy
9,844
+536
+6% +$95.4K 0.04% 337
2014
Q1 		$1.85M Buy
9,308
+428
+5% +$80.8K 0.05% 282
2013
Q4 		$1.7M Buy
8,880
+1,142
+15% +$213K 0.05% 275
2013
Q3 		$1.31M Buy
7,738
+307
+4% +$47.7K 0.04% 288
2013
Q2 		$1.13M Buy
+7,431
New +$1.05M 0.04% 308

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

BB&T Securities's CLB Position: Q3 2019 in Review

BB&T Securities increased its Core Laboratories (CLB) stake by 14% in Q3 2019, buying an estimated $85.4K and bringing the position to 15,214 shares worth $707K. The position accounts for 0.01% of the portfolio, ranked #954.

BB&T Securities first reported a position in CLB in Q2 2013 and has held it in 26 quarters since. The position peaked at $3.02M in Q3 2018. 274 funds tracked by Wall St. Rank hold CLB as of Q3 2019.

  • BB&T Securities held 15,214 shares of Core Laboratories worth $707K as of Q3 2019.
  • BB&T Securities bought 1,836 Core Laboratories shares in Q3 2019, an estimated $85.4K.
  • Core Laboratories made up 0.01% of BB&T Securities's portfolio in Q3 2019, its #954 holding.
  • BB&T Securities first reported a position in Core Laboratories in Q2 2013 and has held it in 26 quarters since.
  • BB&T Securities's Core Laboratories position peaked at $3.02M in Q3 2018.
  • 274 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.